These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9163875)

  • 21. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets.
    Zhang C; Guo L; Jia X; Wang T; Wang J; Sun Z; Wang L; Li X; Tan F; Tian K
    Vaccine; 2015 May; 33(21):2432-7. PubMed ID: 25865469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latency of a thymidine kinase-negative pseudorabies vaccine virus detected by the polymerase chain reaction.
    Volz DM; Lager KM; Mengeling WL
    Arch Virol; 1992; 122(3-4):341-8. PubMed ID: 1309996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication and pathogenicity after intranasal and intracranial inoculation of swine with a recombinant pseudorabies virus containing a deletion at the UL/IR junction.
    Dean HJ; Miller JM; Ackermann MR; Gao XY; Anderson LL; Jacobson CD; Cheung AK
    Virology; 1996 Sep; 223(1):19-28. PubMed ID: 8806536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of Aujeszky's disease virus recombinants from experimentally co-infected swine.
    Dangler CA; Henderson LM; Deaver RE; Bowman LA
    Acta Vet Hung; 1994; 42(2-3):209-12. PubMed ID: 7810414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination of mice and swine with a pseudorabies virus mutant lacking thymidine kinase activity.
    McFarland MD; Hill HT
    Can J Vet Res; 1987 Jul; 51(3):340-4. PubMed ID: 2820561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic engineering of the pseudorabies virus genome to construct live vaccines.
    Post LE; Thomsen DR; Petrovskis EA; Meyer AL; Berlinski PJ; Wardley RC
    J Reprod Fertil Suppl; 1990; 41():97-104. PubMed ID: 2170641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
    Kelling CL; Staudinger WL; Rhodes MB
    Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
    Firkins LD; Weigel RM; Biehl LG; Hahn EC
    Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus reactivation in pigs latently infected with a thymidine kinase negative vaccine strain of pseudorabies virus.
    Mengeling WL
    Arch Virol; 1991; 120(1-2):57-70. PubMed ID: 1656920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK; Schutz JC
    Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
    van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vaccination on lesion development in pseudorabies virus-challenged swine.
    Alva-Valdes R; Glock RD; Kluge JP; Keune CM
    Am J Vet Res; 1983 Apr; 44(4):588-95. PubMed ID: 6307084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
    Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host.
    Dijkstra JM; Gerdts V; Klupp BG; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2147-51. PubMed ID: 9292000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of bivalent vaccine for reproductive failure of swine induced by pseudorabies virus and porcine parvovirus.
    Mengeling WL; Gutekunst DE; Pirtle EC; Paul PS
    Am J Vet Res; 1981 Apr; 42(4):600-3. PubMed ID: 6277213
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential sites of virus latency associated with indigenous pseudorabies viruses in feral swine.
    Romero CH; Meade PN; Homer BL; Shultz JE; Lollis G
    J Wildl Dis; 2003 Jul; 39(3):567-75. PubMed ID: 14567217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of live pseudorabies virus vaccines.
    Kimman TG; Gielkens AL; Glazenburg K; Jacobs L; de Jong MC; Mulder WA; Peeters BP
    Dev Biol Stand; 1995; 84():89-96. PubMed ID: 7796972
    [No Abstract]   [Full Text] [Related]  

  • 40. A novel inactivated gE/gI deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge.
    Gu Z; Dong J; Wang J; Hou C; Sun H; Yang W; Bai J; Jiang P
    Virus Res; 2015 Jan; 195():57-63. PubMed ID: 25240533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.